Area of research
Pulmonary and Respiratory Medicine · Cancer Research
Research interest
Research interests include Renal cell carcinoma treatment, Cancer Genomics and Diagnostics, Renal and related cancers, and Cancer Immunotherapy and Biomarkers.
NCCN Guidelines® Insights: Kidney Cancer, Version 2.2024
Neoplasia risk in patients with Lynch syndrome treated with immune checkpoint blockade
A Phase 2 Trial of Talazoparib and Avelumab in Genomically Defined Metastatic Kidney Cancer
Epidemiology of Renal Cell Carcinoma: 2022 Update
Kidney Cancer, Version 3.2022, NCCN Clinical Practice Guidelines in Oncology
Phase II Trial of Cabozantinib Plus Nivolumab in Patients With Non–Clear-Cell Renal Cell Carcinoma and Genomic Correlates
Diagnostic yield and clinical relevance of expanded genetic testing for cancer patients
Disparities in cancer genetics care by race/ethnicity among pan‐cancer patients with pathogenic germline variants
Efficacy of Cabozantinib in Metastatic MiT Family Translocation Renal Cell Carcinomas
An interdisciplinary consensus on the management of brain metastases in patients with renal cell carcinoma
Genomic and Metabolic Hallmarks of SDH- and FH-deficient Renal Cell Carcinomas
Single-cell sequencing links multiregional immune landscapes and tissue-resident T cells in ccRCC to tumor topology and therapy efficacy
Inherited TP53 Variants and Risk of Prostate Cancer
Uptake and acceptability of a mainstreaming model of hereditary cancer multigene panel testing among patients with ovarian, pancreatic, and prostate cancer
Genetic risk assessment for hereditary renal cell carcinoma: Clinical consensus statement
NCCN Guidelines Insights: Kidney Cancer, Version 1.2021
Practical Considerations and Challenges for Germline Genetic Testing in Patients With Prostate Cancer: Recommendations From the Germline Genetics Working Group of the PCCTC
Familial Kidney Cancer: Implications of New Syndromes and Molecular Insights
Germline Genetic Testing in Advanced Prostate Cancer; Practices and Barriers: Survey Results from the Germline Genetics Working Group of the Prostate Cancer Clinical Trials Consortium
Fumarate hydratase<i>FH</i>c.1431_1433dupAAA (p.Lys477dup) variant is not associated with cancer including renal cell carcinoma
Microsatellite Instability Is Associated With the Presence of Lynch Syndrome Pan-Cancer
Alterations in DNA Damage Response and Repair Genes as Potential Marker of Clinical Benefit From PD-1/PD-L1 Blockade in Advanced Urothelial Cancers
Immune checkpoint inhibitors in MITF family translocation renal cell carcinomas and genetic correlates of exceptional responders
Tumor cell heterogeneity and resistance; report from the 2018 Coffey‐Holden Prostate Cancer Academy Meeting
Mutation Detection in Patients With Advanced Cancer by Universal Sequencing of Cancer-Related Genes in Tumor and Normal DNA vs Guideline-Based Germline Testing
Comparative Genomic Profiling of Matched Primary and Metastatic Tumors in Renal Cell Carcinoma
A Phase Ib Study of BEZ235, a Dual Inhibitor of Phosphatidylinositol 3-Kinase (PI3K) and Mammalian Target of Rapamycin (mTOR), in Patients With Advanced Renal Cell Carcinoma